Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A2MRP in Symptomatic Moderate Knee Osteoarthritis
NCT06329492Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-2-macroglobulin enriched plasma in knee osteoarthritis (OA), sponsored by Mayo Clinic. Started Jan 2024; status: completed.
02
Drugs
alpha-2-macroglobulin enriched plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06329492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329492.